Shijiazhuang Yiling Pharmaceutical Group has obtained production licenses for 7 drugs from the National Medical Products Administration, focusing on new drugs in the fields of hypertension and reproductive health.

Stone Four Pharmaceutical Group (02005.HK) recently announced significant progress in drug research and development. The company has successfully obtained 7 drug production registration approvals issued by the National Medical Products Administration of China, covering multiple medical fields such as hypertension and reproductive health.

Hypertension Treatment Drugs

The hypertension-related drugs approved by the company include:

• Arginine Perindopril Tablets ( 10mg ): Belongs to the chemical drug category 4, regarded as having passed the consistency evaluation, it is the second domestic enterprise to be approved for this type of drug. This medication is mainly used for the treatment of hypertension and congestive heart failure.

• Labetalol Hydrochloride Injection ( 20ml: 100mg ): Belongs to Class 3 chemical drugs, regarded as having passed consistency evaluation. This medication is primarily used for the treatment of various types of hypertension (, especially in hypertensive crises ), to control blood pressure before surgical procedures, to lower blood pressure in pheochromocytoma, and for pregnancy-induced hypertension.

Pharmaceuticals in Reproductive Health

• Progesterone Injection(Ⅱ)(1.112ml:25mg): It belongs to the category of chemical drugs class 3, regarded as passing the consistency evaluation. This drug is mainly used for supplementary treatment of progesterone in assisted reproductive technology(ART), which is of significant importance to women's reproductive health.

Electrolyte Regulation Drugs

• Calcium Chloride Injection ( 10ml: 1g ): Belongs to the category of chemical drugs class 3, regarded as having passed consistency evaluation, primarily used to treat acute hypocalcemia and magnesium poisoning.

• Compound Electrolyte Sodium Acetate Injection (500ml ): Belongs to chemical drugs category 3, equivalent to passing consistency evaluation, mainly used for the treatment of isotonic dehydration accompanied by or expected to have mild acidosis, replenishing the loss of extracellular fluid and blood volume.

• Compound Electrolyte Injection(V)(500ml): Belongs to the chemical drug category 3, considered as having passed the consistency evaluation, primarily used in adults as a source of water, electrolytes, and alkalizing agent.

Respiratory System Medications

• Levosalbutamol Hydrochloride Inhalation Solution(3ml:0.63mg): It belongs to Class 3 chemical drugs and is considered to have passed the consistency evaluation, mainly used for the treatment or prevention of bronchospasm caused by reversible airway obstructive diseases in adults and children over 6 years old. It is worth mentioning that the company's levosalbutamol active pharmaceutical ingredient has been approved and registered by the National Medical Products Administration for use in marketed formulations.

The approval of multiple drug licenses this time indicates the technological strength of Shisi Pharmaceutical Group in the research and production of chemical drugs, particularly in the fields of hypertension treatment and reproductive health. The qualification of "deemed to have passed the consistency evaluation" also means that these drugs meet national standards in terms of quality and efficacy, which is beneficial for enhancing the company's competitive position in the pharmaceutical market.